-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CompilationAspirin
On February 15, 2022 EST, Robert Califf was confirmed by the U.
It is reported that Califf served as FDA commissioner from February 2016 to January 2017
Analysts at RBC Capital Markets applauded the appointment, saying Califf could bring regulatory stability by providing more consistent information
In addition, the RBC team believes that "Califf's experience in big data and preference for large randomized trials may also lead to the beginning of further integration between technology companies and healthcare, particularly in trial design and data analysis"
Califf had to endure bipartisan criticism during the nomination process
Califf's votes for and against are closer than when he was first nominated to lead the FDA
The big decision he faces when he takes over as the FDA is whether to use Pfizer's COVID-19 vaccine in children 6 months to 4 years old
To be nominated, Califf committed to reviewing the accelerated approval process through which Aduhelm received final approval
Reference source: Califf's confirmation as FDA chief gives biopharma industry a 'steady hand' at the agency: analyst
